This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Baker, K. S. Articles by Crist, W. M. Search for Related Content PubMed PubMed Citation Articles by Baker, K. S. Articles by Crist, W. M.

Children From Ethnic Minorities Have Benefited Equally as Other Children From Contemporary Therapy for Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Study Group

From the University of Minnesota, Minneapolis, MN; University of Nebraska Medical Center, Omaha, NE; LeBonheur Children’s Medical Center, Memphis, TN; Johns Hopkins Oncology Center, Baltimore, MD; Columbus Children’s Hospital, Columbus, OH; M.D. Anderson Cancer Center, Houston, TX; Children’s Hospital of Philadelphia, Philadelphia, PA; University of Oklahoma Health Sciences Center, Oklahoma City, OK; Stanford University Medical Center, Stanford, CA; and University of Missouri-Columbia University of Missouri, Columbia, MO.

Address reprint requests to K. Scott Baker, MD, Children’s Oncology Group Operations Center, Publications Office, 440 E Huntington Dr, Arcadia, CA 91066-6012; email: baker084{at}tc.umn.edu

PURPOSE: To define the clinical characteristics of rhabdomyosarcoma (RMS) occurring in children from ethnic minorities and determine whether these children have benefited equally from advances in therapy.

PATIENTS AND METHODS: This was a retrospective cohort analysis of children treated on the Intergroup Rhabdomyosarcoma Study Group protocols between 1984 and 1997. The clinical features and outcomes of 336 African-American children and 286 children from other ethnic minorities were compared with those of white children (n = 1,721).

RESULTS: African-American, other ethnic group, and white children enjoyed similar 5-year failure-free survivals (FFS) of 61%, 61%, and 66%, respectively, P = .15. Compared with white children, nonwhite patients more often had (1) invasive, T2 tumors (P = .03); (2) stage 2 or 3 tumors (P = .003); (3) large tumors (more than 5 cm, P < .006); and/or (4) tumors with positive regional nodes (ie, N1, P = .002). Using Cox proportional hazards analysis, seven patient risk categories were defined with significant differences in outcome. This model was then used to search for other factors associated with FFS after adjusting for these risk categories. Only T stage and age remained associated with FFS (P = .001 and P < .001, respectively). After adjusting for T stage, risk category, and age, we explored the relationship of ethnic group to FFS and found that, compared with whites, the relative risk of failure was 1.14 for African-American patients and 1.2 for other ethnic minority patients, values that are not significantly different.

CONCLUSION: Patients from ethnic minority groups more often have larger, invasive tumors with positive lymph nodes. Nevertheless, they have benefited as equally as white children from the dramatic progress in therapy of RMS.

This article has been cited by other articles:

				M. L. Metzger, S. M. Castellino, M. M. Hudson, S. N. Rai, S. C. Kaste, M. J. Krasin, L. E. Kun, C.-H. Pui, and S. C. Howard Effect of Race on the Outcome of Pediatric Patients With Hodgkin's Lymphoma J. Clin. Oncol., March 10, 2008; 26(8): 1282 - 1288. [Abstract] [Full Text] [PDF]

				D. L. Howell, K. C. Ward, H. D. Austin, J. L. Young, and W. G. Woods Access to Pediatric Cancer Care by Age, Race, and Diagnosis, and Outcomes of Cancer Treatment in Pediatric and Adolescent Patients in the State of Georgia J. Clin. Oncol., October 10, 2007; 25(29): 4610 - 4615. [Abstract] [Full Text] [PDF]

				M. C. Gebhardt Perspectives on Health Disparities in Orthopaedic Oncology J. Am. Acad. Ortho. Surg., September 1, 2007; 15(suppl_1): S5 - S7. [Abstract] [Full Text] [PDF]